Telix Pharmaceuticals Ltd — Major Shareholding Notification 2017

Nov 19, 2017

Form 603 Corporations Act 2001 Section 671B

Notice of Initial Substantial Holder

To: TELIX PHARMACEUTICALS LIMITED

ACN/ARSN:

1. Details of substantial holder (1)

Name: FIL Limited and the entities listed in Annexure A (“FIL”) ACN/ARSN (if applicable)

The holder became a substantial holder on

15 November 2017

2. Details of voting power

The total number of votes attached to all the voting shares in the company or voting interests in the scheme that the substantial holder or an associate (2) had a relevant interest (3) in on the date the substantial holder became a substantial holder are as follows:

Class of Securities(4)	Number of securities	Person’s votes(5)	Voting power(6)
Common stock	19,743,750	19,743,750	10.00%

3. Details of relevant interests

The nature of the relevant interest the substantial holder or an associate had in the following voting securities on the date the substantial holder became a substantial holder are as follows:

Refer to Annexure A

4. Details of present registered holders

The persons registered as holders of the securities referred to in paragraph 3 above are as follows:

Refer to Annexure A

5. Consideration

The consideration paid for each relevant interest referred to in paragraph 3 above, and acquired in the four months prior to the day that the substantial holder became a substantial holder is as follows:

Date of Acquisition	Holder of Relevant Interest	Consideration (9)	Class and Number of Securities
		AUD $	Common stock
09-Nov-17	FIL	0.65	18,635,156
09-Nov-17	FIL	0.65	400,670
09-Nov-17	FIL	0.65	707,924
		**Total Buys **	19,743,750

6. Associates

The reasons the persons named in paragraph 3 above are associates of the substantial holder are as follows:

Name and ACN/ARSN Nature of association (if applicable) N/A

7. Addresses

The addresses of the persons named in this form are as follows:

Refer to Annexure A

Sign Here ______

Dated: 17 November 2017 Kelvin Lo Head of Regulatory Reporting, Asia Pacific Duly authorized under Powers of Attorney by and on behalf of FIL Limited

==> picture [505 x 103] intentionally omitted <==